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Reactive Oxygen Species (ROS)-Activated
ATM-Dependent Phosphorylation of
Cytoplasmic Substrates Identified by
Large-Scale Phosphoproteomics Screen*□S
Sergei V. Kozlov‡, Ashley J. Waardenberg§, Kasper Engholm-Keller¶,
Jonathan W. Arthur§, Mark E. Graham¶, and Martin Lavin‡**
Ataxia-telangiectasia, mutated (ATM) protein plays a cen-
tral role in phosphorylating a network of proteins in re-
sponse to DNA damage. These proteins function in sig-
naling pathways designed to maintain the stability of the
genome and minimize the risk of disease by controlling
cell cycle checkpoints, initiating DNA repair, and regulat-
ing gene expression. ATM kinase can be activated by a
variety of stimuli, including oxidative stress. Here, we
confirmed activation of cytoplasmic ATM by autophos-
phorylation at multiple sites. Then we employed a global
quantitative phosphoproteomics approach to identify cy-
toplasmic proteins altered in their phosphorylation state
in control and ataxia-telangiectasia (A-T) cells in response
to oxidative damage. We demonstrated that ATM was
activated by oxidative damage in the cytoplasm as well as
in the nucleus and identified a total of 9,833 phosphory-
lation sites, including 6,686 high-confidence sites map-
ping to 2,536 unique proteins. A total of 62 differentially
phosphorylated peptides were identified; of these, 43
were phosphorylated in control but not in A-T cells, and 19
varied in their level of phosphorylation. Motif enrichment
analysis of phosphopeptides revealed that consensus
ATM serine glutamine sites were overrepresented. When
considering phosphorylation events, only observed in
control cells (not observed in A-T cells), with predicted
ATM sites phosphoSerine/phosphoThreonine glutamine,
we narrowed this list to 11 candidate ATM-dependent
cytoplasmic proteins. Two of these 11 were previously
described as ATM substrates (HMGA1 and UIMCI/RAP80),
another five were identified in a whole cell extract phos-
phoproteomic screens, and the remaining four proteins
had not been identified previously in DNA damage re-
sponse screens. We validated the phosphorylation of
three of these proteins (oxidative stress responsive 1
(OSR1), HDGF, and ccdc82) as ATM dependent after H2O2
exposure, and another protein (S100A11) demonstrated
ATM-dependence for translocation from the cytoplasm to
the nucleus. These data provide new insights into the acti-
vation of ATM by oxidative stress through identification of
novel substrates for ATM in the cytoplasm. Molecular &
Cellular Proteomics 15: 10.1074/mcp.M115.055723, 1032–
1047, 2016.
Ataxia-telangiectasia (A-T) is a rare, human, autosomal
recessive disease involving complex multisystem defects
characterized by progressive neurological dysfunction, im-
munological abnormalities, growth retardation, and cancer
predisposition (1), caused by mutations in the ataxia-telangiec-
tasia, mutated (ATM)1 protein. ATM is a protein kinase in-
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volved in multiple aspects of cellular metabolism, such as
response to genotoxic stress, cell cycle control, and main-
taining genetic stability (2, 3). The ATM protein plays a role in
phosphorylating a regulatory cascade of proteins controlling
cell cycle progression, DNA repair, transcription, and apopto-
sis, as well as signal transduction pathways responding to
oxidative stress (4). ATM is rapidly activated in the presence
of DNA double strand breaks, yet the mechanism of ATM
kinase activation remains poorly understood. This activation
is dependent on the presence of the Mre11/Rad50/NBN
(MRN) complex (5). Bakkenist and Kastan (6) proposed a
model for ATM activation, where rapid intermolecular auto-
phosphorylation in response to DNA damage caused disso-
ciation of inactive ATM dimers to form active monomers.
It now seems likely that multiple autophosphorylation sites
are involved in ATM activation (7, 8). However, the importance
of autophosphorylation in mice is less clear since mutations
that abolish the autophosphorylation sites do not appear to
interfere with the activation of ATM. ATM kinase can also be
activated by oxidative stress in the absence of DNA damage,
independent of MRE11-RAD50-NBN complex, but involving
autophosphorylation (9). In this case the active form of ATM is
not a monomer but rather a disulfide-linked, covalent dimer,
and the suite of downstream substrates appears to be more
limited than that activated by DNA double strand breaks (5).
More recently, it has been reported that the peroxisome im-
port receptor protein, PEX5, binds ATM and localizes it to
peroxisomes (10). ATM had previously been localized to this
organelle (11). In the latest report, ATM was shown to phos-
phorylate PEX5 at Ser141, which promotes its ubiquitylation to
induce autophagy of peroxisomes (pexophagy). In addition,
activation of ATM should not be viewed in isolation since a
complex set of relationships exist between all DNA-damage-
inducible kinases: ATM, ATR, DNA-PK, and SMG1. Certain
DNA damage stimuli can promote transphosphorylation of
autophosphorylation sites, as was shown in the case of ATR-
ATM and ATM-DNA-PK kinases, and there is also evidence
for cross-regulation between these kinases (12–14). Further-
more, protein phosphatases PP5, PP2A, PP2C and WIP1
have been implicated in the regulation of ATM kinase activity
(15–17). Similarly, regulation of ATM kinase activity by acety-
lation via interaction with acetyltransferases Tip60/KAT5 (18,
19) and hMOF1 has been reported (20).
To understand these complex signaling networks, numer-
ous traditional and proteomic approaches have been utilized
to identify ATM signaling pathways and substrates (reviewed
in (4)). However, there have been some limitations in phos-
phoproteomic screens used to investigate ATM-dependent
signaling pathways. The bulk of these studies employed dif-
ferent cancer cell lines, and A-T cells had not been included.
Phospho-specific antibodies against ATM/ATR substrates
(p(S/T)Q antibodies) were used to identify potential candi-
dates in human embryonic kidney 293T cells (21) or HeLa cells
(22) after DNA damage. Subsequent screens again utilized
cancer cell lines in combination with the ATM inhibitor
KU55933 (23, 24). A quantitative phosphoproteomic SILAC-
based approach used U2OS cells, etoposide, and radiation as
DNA-damaging agents (25) or lymphoblastoid cells treated
with x-ray radiation (26). A number of ATM/ATR signaling
events have also been identified in large-scale phosphopro-
teomic screens of basic cellular functions, e.g. mitosis (27).
Clearly, there exists a need to investigate ATM-dependent
signaling pathways using primary control and A-T cells.
While proteomics screens have created a wealth of infor-
mation on ATM-dependent DNA damage signaling caused by
DNA double strand breaks, it is apparent that they do not
extensively address important functions of ATM kinase out-
side of the nucleus. Several reports provide evidence for a
cytoplasmic localization of ATM (11, 28–30), and this may be
particularly relevant to a role for ATM in responding to oxida-
tive damage in the brain. ATM can be activated by a variety of
stimuli, including oxidative stress, a mechanism not involving
DNA double strand breaks (9). It is not clear at the moment to
what extent overlapping sets of substrates are involved in
ATM signaling in response to DNA double strand breaks
compared with ATM signaling in response to oxidative stress
damage response; HMGA1, high mobility group AT-hook 1 protein;
UIMCI/RAP80, BRCA1-A complex subunit RAP80 protein; HDGF,
Hepatoma-derived growth factor; Ccdc82, Coiled-coil domain-con-
taining protein 82; OSR1, Oxidative Stress Responsive 1 protein
kinase; Mre11, Double-strand break repair protein MRE11A (Meiotic
recombination 11 homolog 1); Rad50, DNA repair protein RAD50;
NBN, Nibrin, Nijmegen breakage syndrome protein 1; MRN, MRE11-
RAD50-NBN complex; PEX5, Peroxisomal targeting signal 1 receptor;
DNA-PK, DNA-dependent protein kinase, catalytic subunit; SMG1,
Serine/threonine-protein kinase SMG1; PP5, Serine/threonine-protein
phosphatase 5; PP2A, Protein phosphatase 2A; PP2C, Protein
phosphatase 2C; WIP1, Protein phosphatase 1D; Tip60/KAT5, Hi-
stone acetyltransferase KAT5; hMOF, Histone acetyltransferase
KAT8; KU55933, 2-(4-Morpholinyl)-6-(1-thianthrenyl)-4H-pyran-4-one;
U2OS,human osteosarcoma cell line; LKB1,Serine/threonine-protein
kinase STK11; AMPK,AMP-activated protein kinase; TSC2,Tuberin;
mTORC1, mammalian target of rapamycin complex 1; Akt, Protein
kinase B; 4E-BP1, Eukaryotic translation initiation factor 4E-binding
protein 1; NEMO,NF-kappa-B essential modulator; TRAF6, TNF re-
ceptor-associated factor 6; Hsp27, Heat shock protein beta-1; HIF1a,
Hypoxia-inducible factor 1-alpha; VAMP2, Vesicle-associated mem-
brane protein 2; KAP1, Transcription intermediary factor 1-beta;
SMC1, Structural maintenance of chromosomes protein 1; H2AX,
Histone H2AX; TCEAL3/6, Transcription elongation factor A protein-
like 3; ATE1, Arginyl-tRNA–protein transferase 1; METTL16, Methyl-
transferase-like protein 16; WNK1, Serine/threonine-protein kinase
WNK1; STRING, Search Tool for the Retrieval of Interacting Genes/
Proteins database; EEA1, Early endosome antigen 1; MAPK1/
ERK2, Mitogen-activated protein kinase 1; MAPK3/ERK1, Mitogen-
activated protein kinase 3; PRAS40, Proline-rich AKT1 substrate 1;
RPTOR, Regulatory-associated protein of mTOR; UREB1, E3 ubiqui-
tin-protein ligase HUWE1; UFD1L, Ubiquitin fusion degradation pro-
tein 1 homolog; ATXN3, Ataxin-3; MON1, Vacuolar fusion protein
MON1 homolog A; TGF, Transforming growth factor beta; PPM1G,
Protein phosphatase 1G; NKCC1, Solute carrier family 12 member 2
protein; NKCC2, Na-K-2Cl cotransporter; NCC, sodium-chloride
symporter.
ROS and ATM-Dependent Cytoplasmic Phosphoproteome
Molecular & Cellular Proteomics 15.3 1033
(31, 32). Indeed, a long-standing debate in the A-T field is the
relative contributions of DNA double strand breaks and oxi-
dative stress to neurodegeneration and neuronal cell death
(33, 34). It was previously demonstrated that kainic acid can
activate ATM in the cytoplasm of neurons of the cerebral
cortex without creating any detectable DNA damage (35). It
seems plausible that this action of kainic acid is mediated by
signaling through reactive oxygen species (ROS). Resveratrol
has been demonstrated to activate ATM in the presence of
ROS (36), suggesting that a phosphoproteomic screen using
resveratrol as an inducer of autophagy (37) potentially uncov-
ers ATM-dependent signaling events independent of DNA
damage. In addition, ATM signaling has been shown to en-
gage the LKB1-AMPK pathway to activate TSC2 in order to
suppress mTORC1 signaling in response to oxidative stress
(38). ATM localization to endosomes (39), peroxisomes and as
yet unidentified cytoplasmic vesicles (11, 40) and mitochon-
dria (41) have all been demonstrated. A number of ATM cy-
toplasmic substrates and interacting proteins have been
identified by a variety of traditional biochemical approaches
(-adaptin, 4E-BP1, B56-PP2A, PP2A/C, LKB1, Akt, NEMO,
TRAF6, Hsp27, HIF1a, VAMP2) (28, 42–50). However, inves-
tigation of the global response of normal and A-T cells to
oxidative stress in the cytoplasm is lacking.
Here, we systematically investigated ATM-dependent sig-
naling events induced by hydrogen peroxide in fibroblasts
derived from normal individuals and A-T patients using a
quantitative phosphoproteomics approach. First, we ad-
dressed the action of ATM kinase in primary cells from A-T
patients, which provided us with a unique opportunity for the
first time to investigate ATM/ATR-dependent signaling path-
ways in a diseased state. Secondly, it was possible to directly
compare the action of an ATM kinase activating stimulus
(H2O2) in the physiological context of nontransformed, non-
immortalized primary control and A-T fibroblasts. The quan-
titative phosphoproteomics approach enabled identification
of 9,612 phosphorylation sites, which were analyzed statisti-
cally. Phosphosites that were changing their level of activity
and/or were lost in the A-T cells were identified as preferen-
tially enriched in the ATM consensus (S/T)Q sites (51), using
an unbiased method. These proteins were also preferentially
enriched for the cytoplasm based on known protein localiza-
tion. Of these phosphosites identified, we validated the phos-
phorylation of three of these proteins (OSR1, HDGF, and
ccdc82) as ATM-dependent after H2O2 exposure and another
protein (S100A11) as ATM dependent for translocation from
the cytoplasm to the nucleus. These data provide new in-
sights into the activation of ATM by oxidative stress through
identification of novel substrates for ATM in the cytoplasm.
EXPERIMENTAL PROCEDURES
Cell Culture and Treatments—Cell cultures of primary neonatal
foreskin fibroblasts (NFF) were established from normal healthy indi-
viduals. Primary cultures of A-T fibroblasts (AT34 ABR) were estab-
lished from skin biopsies of A-T patients obtained in the A-T Clinic
(Royal Children’s Hospital, Brisbane, Australia). All procedures were
approved by the Children’s Health Queensland Hospital and Health
Service Human Research Ethics committee. Fibroblasts cultures were
grown to 80–90% confluence in DMEM supplemented with penicillin,
streptomycin, and either 10% FCS for the normal fibroblasts or 15%
FCS in the case of the A-T fibroblasts. Lymphoblastoid cell lines (LCL)
were established from a normal healthy individual (C3ABR) and an
A-T patient (AT25ABR) by Epstein–Barr virus immortalization. The
lymphoblastoid cell lines were cultured in RPMI 1640 medium with
10% fetal calf serum, 100 units/ml penicillin, and 100 units/ml strep-
tomycin (Life Technologies).
All irradiations were performed at room temperature using a Gam-
macell 40 Exactor research irradiator (1 Gy/min, MDS Nordion, Can-
ada). Treatment of cells with 0.5 mM hydrogen peroxide was per-
formed in the modified media described in (52). Cell monolayers were
quickly washed with warm PBS, then warm HBSS, supplemented
with 2 mM GlutaMAX™ (Life Technologies, Scoresby, VIC, Australia)
and D-glucose (1 g/l) were added to the flasks to produce “untreated”
samples. Hank’s Balanced Salt solution/GlutaMax/glucose also con-
taining 0.5 mM hydrogen peroxide was added to flasks to produce
“H2O2-treated” samples. Flasks were incubated for 30 min, and cells
were quickly rinsed with warm PBS, harvested by detachment
using TrypLE cell-dissociation enzymes (Invitrogen Scoresby, VIC,
Australia), and immediately subjected to subcellular fractionation
(below). Biological replicates of NFF and A-T fibroblasts at early
passage numbers were prepared for phosphoproteomics analysis
in independent experiments.
Experimental Design and Statistical Rationale—Our experimental
design to differentiate between ATM-dependent and ATM-indepen-
dent H2O2 phospho-signaling involved collection of samples from
independent experiments. Cytoplasmic extracts from untreated and
H2O2 treated normal human fibroblasts were collected from four
independent experiments. Similarly, cytoplasmic extracts from un-
treated and H2O2 treated A-T fibroblasts were collected from three
independent experiments. The number of independent experiments
was chosen to be at least three to allow a robust statistical analysis to
be conducted on the data. Replicate 1 from the normal human fibro-
blasts experiment was from an initial test experiment and also in-
cluded in the analysis to maximize on available data.
Subcellular Fractionation of Fibroblasts for Phosphoproteomics—A
subcellular fractionation procedure employing NE-PER™Nuclear and
Cytoplasmic Extraction kit (ThermoScientific Scoresby, Vic, Australia)
was used for isolating cytoplasmic and nuclear protein fractions as
described by the manufacturer. Briefly, collected cell pellets were
resuspended by gentle pipetting in chilled cytoplasmic extraction
reagent I buffer supplemented with protease (50x Complete inhibitor
(Roche) and 1 mM PMSF), phosphatase inhibitors (1 mM Na3VO4, 10
mM NaF, 10 mM Na2MoO, 5 nM okadaic acid, 20 M cantharidin, 10
mM -glycerophosphate) and 1 mM DTT and processed to obtain
cytoplasmic extracts. Nuclear extracts were prepared and kept at
80 °C for signaling experiments. Experimental replicates (n 2 or 3)
of cytoplasmic extracts were pooled and processed as described in
the “Sample Preparation for Phosphoproteomics” section.
Sample Preparation for Phosphoproteomics—Protein concentra-
tion in extracts was measured by BioRad DCTM protein assay, and
cytoplasmic extracts were immediately precipitated with five volumes
of ice-cold acetone–ethanol–acetic acid (50:50:0.1) mixture at
20 °C overnight. Precipitated proteins were recovered by centrifu-
gation at 20,000 g for 1 h at 4 °C. Pellets were washed with 80%
cold ethanol and dried under a gentle stream of nitrogen. Dried
proteins were dissolved in fresh 8 M urea-0.1 M ammonium bicarbon-
ate, reduced with 10 mM DTT, and alkylated with 40 mM iodoacetic
acid. Proteins were digested with LysC/trypsin (1:100 mixture) (Pro-
ROS and ATM-Dependent Cytoplasmic Phosphoproteome
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mega Alexandria, NSW, Australia) using a modified manufacturer’s
protocol. LysC digestion was performed overnight at37 °C using an
Eppendorf thermomixer. Samples were diluted 1:8 with 0.1 M ammo-
nium bicarbonate and an additional amount of trypsin (20 g) was
added to samples. Trypsin digestion was extended by incubating
samples overnight with shaking at 37 °C. Trifluoroacetic acid (TFA)
was added to the samples to 1% final concentration and digests were
clarified by centrifugation at 16,000 g for 10 min. LysC/trypsin digests
of cytoplasmic proteins were purified on 360 mg Sep-Pak C18 Plus
Short cartridges (Waters Rydalmere, NSW, Australia). Peptides were
eluted with 50% acetonitrile, concentrated using a GenVac EZ-2
vacuum evaporator, and the relative concentration of peptides was
measured using a NanoDrop 2000c spectrophotometer (Thermo
Fisher Scientific). Desalted peptides were frozen at 80 °C. Equal
amounts (1 mg) of purified peptides were used in duplex stable
isotope dimethyl labeling as described (53, 54). Briefly, peptides were
adjusted to 125 mM triethylammonium bicarbonate and peptides were
either labeled with “light” formaldehyde (CH2O) and cyanoborohy-
dride (NaBH3CN) or with “heavy” deuterium-containing formaldehyde
(C[2H]2O) and cyanoborohydride (NaB[
2H]3CN) in a total volume of
200 l for 30 min. The labeling reactions were quenched by adding
25% ammonia solution (NH4OH) and then acidified with formic acid.
The reaction volume was reduced by evaporation. The efficiency of
the derivatization was confirmed by LC-MS/MS (see below) to be
greater than 95% before the “light” and “heavy” samples were mixed.
Phosphopeptides in the labeled mixtures were enriched using
methods similar to those described previously (55, 56). Briefly, sam-
ples in 50% acetonitrile/0.1% TFA were applied to Fe3 immobilized
metal affinity chromatography beads (PhosSelect, Sigma Castle Hill,
NSW, Australia) and washed in the same solution. The peptides that
did not bind, primarily nonphosphopeptides, were kept for later anal-
ysis. The monophosphorylated peptides were eluted using 20% ace-
tonitrile/1% TFA. The multiphosphorylated peptides were eluted in a
high pH solution (20% acetonitrile with 20% ammonium hydroxide
solution (29% ammonia in water)). Monophosphorylated peptides
were further fractionated using TiO2 and hydrophilic interaction liquid
chromatography chromatography. Monophosphorylated peptides
were applied to TiO2 beads in a solution of 5% TFA 80% acetonitrile,
washed in 50% acetonitrile/5% TFA, and eluted with high pH solution.
The eluate was immediately concentrated by evaporation and ad-
justed to the starting conditions of HILIC chromatography (90% ace-
tonitrile/0.1% TFA). HILIC separation was performed using a Dionex
UltiMate3000 nano HPLC system (Thermo Fisher Scientific). The
monophosphorylated-peptide-enriched sample was then loaded onto
a TSKgel Amide-80 HILIC 1 mm  250 mm column (Tosoh Biosci-
ence, Tokyo, Japan) using gradient elution from 90% ACN, 0.1% TFA
to 60% ACN, 0.1% TFA for 35 min at 50 l/min. Fractions were
collected in a 96-well plate, evaporated by vacuum centrifugation,
and redissolved in 5 l of 0.1% formic acid. Ten percent of the
nonphosphopeptides, the single multiphosphopeptide fraction, and
the multiple monophosphopeptide fractions were analyzed separately
by LC-MS/MS.
LC/MS/MS Analysis—Analysis of peptide fractions was performed
using a Dionex UltiMate 3000 nanoLC system and an LTQ Orbitrap
Velos mass spectrometer (Thermo Fisher Scientific). Each 5 l frac-
tion was loaded at 400 nl/min of 100% phase A (0.1% formic acid in
water) for 20 min onto a 35 cm  75 m inside diameter column
packed with ReproSil-Pur 120 C18-AQ 3 m beads (Dr. Maisch
Ammerbuch-Entringen, Germany). The column was heated to 45 °C.
The gradient was from 2% phase B (0.1% formic acid, 9.99% water,
and 90% acetonitrile) to 30% phase B in 152 min and then to 99%
phase B in 5 min. During each cycle of data-dependent MS detection,
the seven most-intense ions within m/z 300–1,500 above 500 counts
in a 30,000 resolution Orbitrap MS scan were selected for fragmen-
tation and detection in an Orbitrap MS/MS scan at 7,500 resolution.
Other MS settings were: isolation width, 1.5 units; normalized collision
energy, 42; activation time, 0.1 ms; Fourier transform first m/z, 140;
Fourier transform master scan preview was enabled; monoisotopic
precursor selection was enabled (unassigned charge state and
charge state 1 rejected); predict ion injection time was enabled;
dynamic exclusion was for 20 s with 10 ppm mass width; Orbitrap
target was 1,000,000 counts for a maximum of 500 ms for MS scans
and a target of 50,000 counts for amaximumof 300ms forMS/MS scans.
Bioinformatics Analysis—The raw MS files were processed using
MaxQuant 1.3.0.5 (57) (Max Planck Institute of Biochemistry) and the
human reference proteome from UniProtKB (UP000005640, down-
loaded 9 July 2014, 68,049 entries). Peptides were assumed to have
resulted from trypsin cleavage, including [K/R]/P cleavages, with a
maximum of three missed cleavages. All other MaxQuant settings
were default except for the following: variable modifications were
phosphorylation (STY), acetyl (protein N-term), deamidation (NQ),
oxidation (M), carbamidomethyl (C), dioxidation (C), and trioxidation
(C), the minimum peptide length was 6, maximum labeled amino
acids was 5, minimum peptide score was 40. The normalized ratios,
together with phosphopeptide and protein annotations in the “Phos-
pho (STY) sites.txt” output file, were exported for further analysis in R,
version 3.1.1 (The R Foundation). Phosphopeptides not containing
sites with a localization score  0.75 were excluded from further
analysis. The mass spectrometry proteomics data have been depos-
ited to the ProteomeXchange Consortium (58) via the PRIDE partner
repository with the dataset identifier PXD002850.
Normalization and Rank Product Analysis—We generated four sets
using the nonparametric rank product method (59) based on how
many times a phosphopeptide was reported across independent
experiments. No thresholding based on the magnitude of change in
phosphorylation level was performed; however, phosphopeptides not
passing a false discovery rate of 0.20 were discarded after statistical
analysis (see below). If phosphopeptides were present in at least two
A-T and two control samples, we deemed this set suitable for a
two-class comparison, i.e. direct comparison of phosphorylation lev-
els (Set 1). For two-class comparisons the rank product method can
be sensitive to insufficiently normalized data due to the determination
of ratios between contrasts prior to ranking (59). Therefore, for Set 1,
data were log2 transformed, followed by quantile normalization as-
suming missing values were missing at random (60). Missing value
imputation was then undertaken using the k-nearest neighbor method
(KNNimpute) with k  10 (61) and data iteratively reweighted using
surrogate variable analysis (SVA) (62). This improved separation of
A-T and NFF samples as observed using unsupervised principle
component analysis (Supplemental Fig. 5 and Fig. 4B).
To test for cases where phosphorylation was preferentially de-
tected, we employed a single class test (Sets 2–4). Normalized ratios
from MaxQuant were converted to ranks, and the rank products were
directly calculated from replicates. Here “preferentially” is defined as
present in at least two of three samples for A-T and three of four
samples for NFF but not detected in at least two samples of their
respective contrast samples. Set 4 indicated the peptides commonly
phosphorylated in both A-T and NFF cells, i.e. not differentially phos-
phorylated, but indeed phosphorylated. The overall schema is repre-
sented in Fig. 3 and summarized below:
1) detected in A-T and control cell lines (n  2) and differentially
phosphorylated
2) regulated phosphorylation detected preferentially in A-T cells
(n  2)
3) regulated phosphorylation detected preferentially in control
cells (n  3)
4) similarly regulated phosphorylation detected in both A-T and
control cell lines
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p values and false discovery rates (FDR) were then determined
using the rank product method implemented in the RankProd R
package (version 2.34) using 1,000 permutations (63). We used an
FDR threshold of 0.20 to define significant phosphorylated peptides in
each set. If a phosphopeptide for Set 1 was present in Sets 2–4, it
was removed after the FDR calculation since it was already catego-
rized as differentially phosphorylated according to our criteria, while
maintaining the maximum number of phosphopeptides for FDR cal-
culation. This resulted in a total of 101 phosphopeptides comprising
19, 17, 43, and 22 peptides for Sets 1, 2, 3, and 4, respectively. When
analyzing proteins, we extracted the leading protein annotation for
further analysis.
Gene Ontology Enrichment—Gene ontology (GO) enrichment of
cytoplasmic and nuclear terms was performed using the Database for
Annotation Visualization and Integrated Discovery database (64).
Analysis of the “cytoplasm” and “nuclear” term associated with the
identified proteins from the “SP_PIR_KEYWORDS” ontology were
compared and fold enrichment (also known as the odds ratio) re-
ported. Inputs were the leading protein annotations, and the analysis
was conducted with the species set to Homo sapiens and all other
parameters set to their default value (default background is the whole
genome). The p values reported were derived from Database for
Annotation Visualization and Integrated Discovery gene ontology
charts and corresponded to a modified Fisher’s Exact Test.
Motif Enrichment Analysis—Phosphopeptides identified in Sets
1–4 were tested for motif overrepresentation using Motif-x (65). Input
sequences were centered on the modification site and trimmed to 13
amino acids. A background sequence set representing all 6,650
phosphopeptides identified (p  0.75) was generated for analysis.
Central characters “S” and “T” were analyzed separately and motifs
were considered enriched at p  0.01. Motifs with greater than two
foreground hits were reported.
Comparison to Previously Published Proteomics Data—Briefly, Beli
et al. (25) induced DNA damage via ionizing radiation (IR) for 1 h or
etoposide treatment for 24 h and compared with nontreated controls.
SILAC labeling was performed using whole-cell fractions and final
ratios determined using MaxQuant. Nonthresholded data from Max-
Quant were downloaded as per Table S1 from the Beli et al. 2012
publication for comparison. Two tables were subsequently generated
for comparison to etoposide and IR data separately. All comparisons
performed used the “Modified.Sequence” string reported by Max-
Quant for each peptide identified.
Cell Extracts, ATM Immunoprecipitation, and ATM MS Analysis—
Total cell extracts were prepared by lysing cells in Nonidet P-40 lysis
buffer containing phosphatase and protease inhibitors (66). Sheep
polyclonal ATM antibodies were used to immunoprecipitate ATM
protein, separate it on biphasic 5%/12% SDS-polyacrylamide gels,
and transfer to nitrocellulose membrane as described (7). ATM2C1,
phospho-S367 ATM, phospho-S1981 ATM, and phospho-S2996
ATM antibodies were used to probe membranes sequentially with
stripping between each step. ATM immunoprecipitations were scaled
up to obtain ATM protein for mass spectrometry analysis. Identifica-
tion of ATM phosphorylation sites by MS was performed essentially
as described in (8).
Immunoblotting, Immunoprecipitation, and Antibodies—For immu-
noblotting, 50 g of cell extracts were electrophoresed on NuPAGE
4–12% Bis-Tris mini gels and transferred to nitrocellulose mem-
branes (Amersham Biosciences Parramatta, NSW, Australia). Mem-
branes probed with antibodies were visualized with the Western
Lightning PLUS ECL substrate (Perkin Elmer Melbourne, VIC, Austra-
lia). For immunoprecipitation of proteins phosphorylated on p(S/T)Q
motifs, total cellular extracts prepared using Nonidet P-40 lysis buffer
were immunoprecipitated with a mixture of phospho (S/T) ATM/ATR
substrate rabbit polyclonal and phospho ATM/ATR substrate (SQ)
rabbit monoclonal antibodies. Immunoprecipitates were separated on
NuPAGE 4–12% Bis-Tris mini gels and transferred to nitrocellulose
membranes. Membranes were stained with PonceauS and scanned
to estimate immunoprecipitation efficiency and loading. Membranes
were blocked with 5% skim milk powder in TBS/0.1% Tween20 and
probed with antibodies against candidate proteins identified in the
phosphoproteomics screen. Membranes were stripped of antibodies
by incubation in 62.5 mM Tris-HCl (pH 6.8), 2%SDS, and 100 mM
-mercaptoethanol at 60C for 30 min. Membranes were washed in
PBS-Tween, reblocked, and incubated with primary antibody.
ATM-specific sheep antibodies, pS367-ATM, and pS2996-ATM
rabbit antibodies were prepared as described earlier (7, 8). ATM 2C1
mouse monoclonal and anti-DNAPKcs (phospho S2056) rabbit poly-
clonal antibodies were from Abcam (Melbourne, VIC, Australia). Anti-
DNA-PK mouse monoclonal antibodies were from Calbiochem
(Merck Millipore, Bayswater, VIC, Australia). ATM (pS1981) rabbit
monoclonal, Mre11–2D7 mouse monoclonal, phospho-S957 SMC1
rabbit monoclonal antibodies were from GeneTex (Irvine, CA, USA).
Phospho-ATR (Ser428) phospho (S/T) ATM/ATR substrate rabbit
polyclonal, phospho ATM/ATR substrate (SQ) rabbit monoclonal,
phospho-S15 p53 rabbit polyclonal, and phospho-T68 Chk2 rabbit
polyclonal antibodies were from Cell Signaling Technology (Gen-
esearch Pty Ltd,Arundel,QLD, Australia). KAP1 rabbit polyclonal,
phospho-S824 KAP rabbit polyclonal, Nbs1 rabbit polyclonal, phos-
pho-S343 Nbs1 rabbit polyclonal, and SMC1 rabbit polyclonal anti-
bodies were from NOVUS Biologicals (Noble Park North, VIC, Aus-
tralia). ATR N-19 goat polyclonal and p53 (Pab 1801) mouse
monoclonal antibodies were from Santa-Cruz Biotechnology (VWR
International, Murarrie,QLD, Australia). Rad50–2C6 mouse monoclo-
nal, -H2AX (pS139) mouse monoclonal, and Chk2 rabbit polyclonal
antibodies were from Merck Millipore. OSR1 rabbit polyclonal,
S100A11 rabbit polyclonal, HDGF rabbit polyclonal, ccdc82 rabbit
polyclonal, ATE1 rabbit polyclonal, TCEAL3/6 rabbit polyclonal, and
METTL16 rabbit polyclonal antibodies were from One World Labs
(San Diego, CA, USA).
IF Microscopy—Saponin permeabilization technique was used for
Immunofluorescence microscopy of cytoplasmic proteins. Briefly,
early passage control and A-T fibroblasts were seeded on glass round
coverslips, treated with 0.5 mM H2O2 for 30 min in a medium used for
preparation of extracts in phosphoproteomics experiments (HBSS:
glucose:GlutaMAX™). Cells were fixed with 4% paraformaldehyde in
cytoskeletal buffer for 15 min, permeabilized with 0.2% saponin in
cytoskeletal buffer for 10 min and blocked with 0.5% BSA/5% FCS
in PBS. The following antibodies were used for immunofluorescence
microscopy: S100A11 rabbit polyclonal (One World Labs), anti-EEA1
mouse monoclonal (BD Transduction Laboratories North Ryde, NSW,
Australia), and H2AX (pS139) mouse monoclonal (Merck Millipore).
Coverslips were incubated with S100A11 (1/100) and EEA1 (1/250)
antibodies overnight at 4 °C in 0.1% saponin/0.5% BSA/5% FCS/
PBS. Coverslips were washed with PBS and incubated with
-mouse-Alexa594 (highly-crosslinked), and -rabbit-Alexa488
(highly cross-linked) (Life Technologies) secondary antibodies at room
temperature for 1 h. For detection of H2AX foci, cells were permea-
bilized with 0.5% Triton X-100 in cytoskeletal buffer for 10 min and
then processed as described above using H2AX antibody (1/1,000).
Cells were stained with DAPI, coverslips mounted in ProLong® Gold
antifade mountant (Life Technologies), and imaged on Zeiss AxioIm-
ager M1 fluorescent microscope equipped with Axiocam503 mono
camera using x63 oil lens. Images were processed using ZEN soft-
ware (Zeiss North Ryde, NSW, Australia).
RESULTS
Oxidative Stress Induces ATM Autophosphorylation at Mul-
tiple Sites—Autophosphorylation of ATM can be induced by
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ionizing radiation (IR) at a number of different sites (6, 7) and
S1981 by oxidative stress (9). We initially compared ATM
autophosphorylation in nuclear extracts after exposure of pri-
mary neonatal foreskin fibroblasts (NFFs) to IR and oxidative
stress (H2O2 treatment). Detection of similarly increased
phosphorylation at Ser1981, Ser2996, and Ser367 by site-spe-
cific antibodies demonstrated that both agents induce acti-
vation of ATM via multi-site autophosphorylation (Fig. 1A). To
monitor the purity of nuclear and cytoplasmic fractions, we
carried out immunoblotting for a number of proteins from
each compartment (Fig. 1B). Under these conditions both
H2O2- and IR-induced H2AX foci both in control and A-T
fibroblasts (Supplemental Fig. 1).
Oxidative Stress and Ionizing Radiation Activate Cytoplas-
mic ATM—It is well established that the bulk of ATM protein is
present in the nucleus, but the presence of cytoplasmic ATM
has been reported in some cell types (29, 40). To address this,
we initially determined whether cytoplasmic ATM was acti-
vated by IR. The results in Fig. 1C revealed that cytoplasmic
ATM was activated by IR as determined by phosphorylation
on Ser1981 and Ser2996. The amount of activity was 25% of
that observed with nuclear ATM. This is in agreement with
the relative amounts of ATM protein in the nucleus and
cytoplasm. We then determined whether H2O2 could also
activate ATM in both the nucleus and in the cytoplasm of
primary control fibroblasts. We observed robust activation
of ATM, as determined by phosphorylation of Ser1981 in total
cell extracts (Fig. 1D). The bulk of this activation was ob-
served in nuclear extracts; however, activation was also
clearly detectable in the cytoplasmic fraction. The extent of
activation by H2O2 was comparable to exposure to IR (Fig.
1C and Fig. 1D). Similarly, increased phosphorylation was
observed for Ser2996 and Ser367, both of which have been
shown to be functionally important for ATM activation by
DNA damage (8).
We have previously employed stable isotope dimethyl la-
beling to quantitate the relative change in abundance of ATM
phosphorylation sites after stimulus by IR (8). We employed
the same approach here to compare untreated and H2O2-
treated cells. Similar to the detection of increased phosphor-
FIG. 1. ATM kinase activation by ionizing radiation (IR) and H2O2 in subcellular fractions. Normal human fibroblasts (NFF) were
irradiated with 6 Gy or treated with 0.5 mM H2O2. NFF and A-T fibroblasts total, cytoplasmic, and nuclear extracts were prepared as
described in the Methods and immunoprecipitated with anti-ATM antibody. Immunoprecipitated ATM was resolved on biphasic
5%/12% SDS-Polyacrylamide gel and Western blotting was performed with phospho-specific ATM antibodies. Variation in total ATM
protein levels represents the different amount of ATM kinase present in subcellular fractions after immunoprecipitation. (A) ATM kinase
activation by ionizing radiation (IR) and H2O2 in nuclear fractions prepared from normal human fibroblasts (NFF). Activation was determined by
ATM autophosphorylation using antibodies against different active forms. (B) Monitoring of subcellular fractionation using specific markers.
Cytoplasmic proteins: tubulin and GAPDH; Nuclear proteins: histone H3, SMC1, and KAP1 (C) Active ATM kinase is detected in total extracts,
nuclear and cytoplasmic fractions from NFF using phospho-specific antibodies against ATM. (D) ATM kinase activation induced either by IR
or H2O2 in total cell extracts, cytoplasmic and nuclear extracts.
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ylation by phosphosite-specific antibodies (Fig. 1D), we ob-
served increased phosphorylation at Ser1981, Ser367, and
Ser2996 following H2O2 treatment of both lymphoblastoid cells
and fibroblasts (Supplemental Fig. 2). IR nonresponsive ATM
site, Thr1885 (8) was similarly nonresponsive after H2O2 treat-
ment. Thus, cytoplasmic ATM is autophosphorylated at three
major sites following H2O2 treatment, and these sites are
associated with ATM activation.
Activation of Additional Phosphoinositide-3-Like Kinases
and Downstream Substrates—The three phosphoinositide-3-
like kinases (PIKK), ATM, ATR, and DNA-PK, are all DNA
damage response proteins and have overlapping substrate
phosphorylation motifs (S/T)Q (51). Apart from ATM, other
PIKK family members might be involved in the response to
oxidative stress. To determine if other PIKK members are
activated by H2O2, we monitored their activation and signal-
ing alongside ATM in control fibroblasts and compared these
results with A-T fibroblasts. Autophosphorylation of ATR on
Ser428 was detected in control fibroblasts after IR and H2O2
treatment but not in A-T fibroblasts (Fig. 2A), indicating that it
is potentially ATM dependent. Ser428 has been suggested to
be a marker of ATR activation (67). Autophosphorylation on
Ser2056 is an indicator of DNA-PK activation (68). Ser2056
phosphorylation was induced by H2O2 in both control and A-T
fibroblasts (Fig. 2A), indicating its activation might be inde-
pendent of ATM. The results in Fig. 2B outline downstream
substrate signaling induced by IR and H2O2. It is evident from
the absence of phosphorylation in A-T fibroblasts that the
majority of these phosphorylations can be accounted for by
ATM or ATR activation. On the other hand, it seems likely that
ATM and DNA-PK could contribute to KAP1 phosphorylation.
Thus, H2O2 treatment is likely to activate multiple PIKK family
proteins. Overall, the data suggest ATM and ATR might be
synergistically activated by H2O2 treatment, while DNA-PK
signaling is likely to be independent of ATM. In support of this,
activation of ATR and DNA-PK has already been reported
(69, 70).
Identification of Potential Cytoplasmic ATM Substrates Fol-
lowing Oxidative Stress—To identify potential cytoplasmic
ATM substrates and signaling pathways following H2O2 ex-
posure, we performed a comparative phosphoproteomics ex-
periment. As above, cytoplasmic extracts from untreated and
H2O2-treated normal human fibroblasts were compared in
four independent experiments. Additionally, cytoplasmic ex-
tracts from untreated and H2O2-treated A-T fibroblasts were
compared in three independent experiments to aid in deter-
mining whether the observations in normal human fibroblasts
are a result of ATM signaling. Quantitation of the differences
between untreated and treated was enabled by duplex stable
isotope dimethyl labeling (53, 54). Samples were analyzed by
high-resolution mass spectrometry with an LTQ Orbitrap Ve-
los, and the raw data were processed using MaxQuant (57).
Phosphopeptide enrichment was performed utilizing the TiO2
-SIMAC -HILIC technique (56), which involves fractionation of
phosphopeptides via HILIC to increase the depth of phospho-
proteome discovery. The strategy is outlined in Fig. 3A. Acti-
vation of ATM was confirmed for each biological replicate by
monitoring the phosphorylation of known ATM substrates
KAP1 and SMC1 by Western blotting of the normal human
fibroblast lysates (Supplemental Fig. 3). ATM was reproduc-
ibly activated in each replicate.
A total of 9,833 phosphorylated sites were identified (8,763
unique), mapping to 2,716 proteins, at a false discovery rate
of 1% at both the peptide and protein level (Supplemental
Table I). A subset of these, 6,686, were high-confidence sites
containing at least one site with a localization score  0.75
(Fig. 3B and Supplemental Table I), mapping to 2,536 unique
proteins (Fig. 3C). The complete MaxQuant result files for the
phosphopeptide identification and quantification are supplied
as supplementary material. For normal human fibroblasts and
A-T fibroblasts, preferential enrichment for cytoplasmic pro-
FIG. 2. (A) Activation of DNA damage response kinases by IR and
H2O2 in normal human fibroblasts and A-T primary fibroblasts. Normal
human fibroblasts (NFF) and A-T fibroblasts were irradiated with 6 Gy
or treated with 0.5 mM H2O2. Total extracts were prepared as de-
scribed in the Methods, and samples were run on NuPAGE 3–8%
tris-acetate mini gels. Western blotting was performed with phospho-
specific ATM, ATR, and DNA-PK antibodies as indicated. (B) ATM-
dependent signaling in response to IR and H2O2 in normal human
fibroblasts and A-T primary fibroblasts. Normal human fibroblasts
(NFF) and A-T fibroblasts were irradiated with 6 Gy or treated with 0.5
mM H2O2. Total extracts were prepared as described in the Methods
and samples were run on NuPAGE 4–12% Bis-Tris mini gels. Western
blotting was performed with phospho-specific antibodies against
known ATM substrates as indicated.
ROS and ATM-Dependent Cytoplasmic Phosphoproteome
1038 Molecular & Cellular Proteomics 15.3
teins over nuclear proteins was observed (Fig. 3D). A subset
of 213 and 220 phosphorylated peptides were in a (S/T)Q
context in the normal human fibroblasts (n  4) and A-T
fibroblasts (n  3), respectively; 203 were present in both
normal and A-T (Fig. 3C). We compared all phosphorylated
peptides that we identified to Beli et al. (25) since this is one
of the few studies that captured cytoplasmic phosphopep-
tides in a DNA damage model. In total, Beli et al. identified
21,249 unique modified sequences, 11,776 and 13,177 for IR
and etoposide, respectively. A relatively small number, 3,704
unique modified sequences, were in common between IR and
etoposide. Of the total set 1,046 were in the p(S/T)Q context,
141 in common with IR and etoposide treatment. Of the 8,618
unique modified sequences (nonthresholded) in our dataset,
2,521 (29%) overlapped with those identified by Beli et al.
(Supplemental Fig. 4A), 1,751 and 1,717 with IR and etopo-
side, respectively. We identified 321 unique p(S/T)Q-modified
sequences in our complete data (H202 treated and untreated
A-T and control data combined). Eighty-three (26%) of these
unique phosphopeptides were also identified in the Beli et al.
data set; IR (66) and etoposide (45) data set (Supplemental
Fig. 4B).
The quantitative information for each high-confidence
phosphopeptide was used to examine the changes in phos-
phopeptide abundance between the normal human fibro-
blasts and A-T fibroblasts following H2O2 treatment. This was
done by extracting data sets that represent phosphorylated
peptides identified as differentially or preferentially phosphor-
ylated in each of the two cell types (normal human fibroblasts
and A-T fibroblasts), resulting in four data sets (Fig. 4). Set 1
FIG. 3. Phosphoproteomics workflow and identified phosphopeptides. (A) Cultures of NFF and A-T cells were mock-treated or treated
with H2O2. Cytoplasmic extracts of each were prepared, digested, and duplex stable isotope dimethyl labeled. Phosphopeptides were enriched
and fractionated using the TiSH method and analyzed by LC-MS/MS. (B) Localization probability distribution of phosphosites identified using
MaxQuant. (C) Counts of phosphopeptides and proteins at the thresholds used; p indicates localization probability. (D) Enrichment of
cytoplasm and nucleus GO terms for the A-T and normal cells.
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consisted of differentially phosphorylated peptides, i.e. pep-
tides phosphorylated in both normal human fibroblasts and
A-T fibroblasts but where the change in phosphorylation upon
treatment with H2O2 differed. For Set 1 (Figs. 4A–4C), data
were first normalized, missing values imputed, and surrogate
variable analysis performed for suitability to a two-class rank
product analysis. A clear separation and clustering of A-T
from normal human fibroblasts was observed through appli-
cation of unsupervised principle component analysis prior to
rank product analysis (Fig. 4B and Supplemental Fig. 5). At a
false discovery rate (FDR) threshold of 0.2 and employing
1,000 permutations to determine the FDR, we identified 19
peptides as differentially phosphorylated. These included 14
with increased phosphorylation in normal fibroblasts and five
with decreased phosphorylation (Fig. 4C).
Sets 2 and 3 were allowed to have completely missing
values for either normal or A-T fibroblasts, respectively, that
is, the phosphopeptide was absent (i.e. not detected) in at
least two replicates for both normal and A-T samples as per
Set 1 inclusion criteria. Set 4 consisted of phosphopeptides
that changed to a similar extent in both cells types, i.e. not
differentially phosphorylated as per Set 1. Thus, these remain-
ing sets were generated using a single class rank product
analysis (FDR  0.2) to identify phosphopeptides specifically
dysregulated by H2O2 in normal and/or A-T (Fig. 4D, bottom
panel). Set 2 consisted of sites that changed preferentially in
A-T fibroblasts, and 17 peptides fit this criterion. Set 3 con-
sisted of phosphopeptides that preferentially changed in nor-
mal fibroblasts, and 43 fit this criterion. These latter peptides
are most likely to contain potential ATM substrates because
FIG. 4. Analysis of phosphoproteomics data set by rank product statistics. (A) Overview of normalization process for Set 1; quantile
global normalization was followed by missing value imputation, surrogate variable analysis, and rank product analysis. (B) Principle component
analysis projecting the first and third components of Set 1 data after normalization. (C) Heat map illustrating overall patterns for the peptides
identified in Set 1. (D) Heat maps for Sets 2–4. The number of solid boxes indicates the number of times a phosphopeptide must be detected
at to be included in the set. The number of boxes with diagonal lines indicates the number of times a that missing values for a particular
phosphopeptide was permitted.
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they were absent or not significantly changing in A-T fibro-
blasts. Set 4 consisted of phosphopeptides that changed in
both control or A-T fibroblasts, and 22 of these peptides fit
this criterion. This latter set is the least likely to contain ATM
substrates because of the similar H2O2 response in ATM-
defective cells. In summary, a total of 101 significantly regu-
lated phosphopeptides were identified and classified as dif-
ferentially or preferentially phosphorylated.
To confirm that the regulated phosphopeptides identified in
these four sets were of cytoplasmic origin, we performed
gene ontology (GO) analysis using the Database for Annota-
tion Visualization and Integrated Discovery database (64) on
the proteins containing the identified phosphorylation sites.
Extraction of cytoplasm and nuclear terms revealed that the
odds of the Set 1–4 proteins being associated with cytoplas-
mic terms was approximately twice the odds of being en-
riched for nuclear terms. Nuclear protein terms were close to
null enrichment (approaching an odds ratio of 1) when com-
pared with the background distribution (Supplemental Fig.
6A). Set 2 was not enriched for any GO terms, suggesting that
there was not a consistent signature for the proteins harboring
phosphosites in A-T only cells. Sets 1, 3, and 4 were each
significantly enriched for the cytoplasm term (p values 0.023,
2.86E-05, and 4.83E-04, respectively) in contrast to the nu-
clear term (p values 0.633, 0.140, and 0.421, respectively)
supporting cytoplasmic enrichment of our regulated phos-
phopeptide data.
We next performed motif enrichment analysis of modified
sequences centered on the serine or threonine amino acid
using Motif-x (65). The top motif for Set 1 was SXXD, indicat-
ing that these phosphopeptides might be substrates of an
acidophilic protein kinase (Fig. 5A). The top motif identified for
Set 3 was the consensus ATM substrate threonine glutamine
sequence (p  0.01) (Fig. 5B). No SQ sites were significantly
overrepresented in Sets 2 or 4. No TQ sites were identified as
significantly overrepresented. Annotation of all (S/T)Q-con-
taining sequences identified three Set 1 phosphopeptides:
Thr23 of thymosin 4 and Ser101 of S100 calcium-binding
protein A11 (S100A11) had increased phosphorylation and
Ser99 of 72 kDa inositol polyphosphate 5-phosphatase had
decreased phosphorylation in normal cells. Eight Set 3 (S/T)Q
sites were also identified and will be discussed in greater
detail below. Although Set 4 was not overrepresented in SQ
motifs, a single SQ site at Ser167 of WNK lysine-deficient
protein kinase 1 was identified and associated with increased
phosphorylation.
Using an unbiased approach, we confirmed that predicted
ATM substrates existed in the most relevant sets. Prediction
of ATM targets from Set 1–4 phosphopeptide sequences was
performed using NetPhosK (71), which uses neural network
predictions. NetPhosK identified the greatest proportion of
predicted ATM targets in Set 1 (21%) and Set 3 (23.4%),
compared with Set 2 (0%) and Set 4 (0.05%) (Supplemental
Fig. 6B). This was consistent with our ranked product analysis
where we expected to find ATM targets in Set 1 and Set 3
preferentially.
Our experimental and bioinformatics approach therefore
enabled us to narrow the reactive oxygen species phospho-
signaling to (1) events occurring in, or preferentially in, normal
cells but not in A-T cells, (Fig. 4, Set 1 and 3), (2) those
significantly enriched for cytoplasm terms, and (3) those pre-
dicted to be ATM targets. In this narrow group, we observed
11 proteins phosphorylated at (S/T)Q sites. Of these, HMGA1,
involved in p53 transcription regulation, is a previously de-
scribed ATM substrate (72). UIMCI (RAP80), recruited to the
sites of DNA double strand breaks, is also phosphorylated by
ATM (73). Five other proteins, ATE1, METTL16, OSR1,
PPM1G, and TCEAL3, have been identified in phosphopro-
FIG. 5. Potential protein kinase substrate motifs and regulated p(S/T)Q sites. (A) MotifX analysis of Sets 1–3. (B) Heatmap showing log2
ratio values of p(S/T)Q containing phosphopeptides in Sets 1–4.
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teomic screens of the DNA damage response (21, 25, 26). A
non-(S/T)Q site of OSR1 was in Set 3 (Ser359). Phospho-
Ser427 was detected twice in normal cells but not in A-T cells.
However, it was below our false discovery threshold. The four
remaining candidates have not been described previously in
DNA damage screens and potentially represent novel ATM-
dependent signaling targets.
In order to establish the signaling pathways affected by
ROS, we performed network analysis using Ingenuity Path-
way Analysis (IPA, Qiagen) and STRING (74), incorporating
candidates identified from Sets 1–4 (Fig. 4). A summary of
pathways impacted on appears in Supplemental Fig. 7. ROS
is known to activate MAPK and PI3K/AKT signaling (75).
Activation of these pathways was evident by changes to the
abundance of phosphosites of Set 4 proteins Nck-interacting
kinase (MAP4K4), MAPK1/ERK2, and MAPK3/ERK1, PRAS40
(AKT1S1), and to Set 1 protein RPTOR. Substrates of ATM
and network neighbors are shown (Supplemental Fig. 7), pre-
dominantly arising from Set 3. A small cluster of these pro-
teins are involved in ubiquitin-mediated protein degradation
(ATE1, UREB1 (HUWE1), and UFD1L).
Validation of Candidate (S/T)Q Phosphosite Proteins—We
selected several candidates from Set 1 and Set 3 showing
up-regulation of phosphorylation on (S/T)Q motifs (see Fig. 5).
Since no phospho-specific antibodies were available against
the identified sites on these proteins, we carried out protein
immunoprecipitation with an antibodies recognizing the ATM/
ATR substrate motif p(S/T)Q followed by immunoblotting for
the specific protein. Increased phosphorylation of the candi-
date protein OSR1 was detected in response to H2O2 treat-
ment (Fig. 6A), which we attribute to the Ser427 phosphosite
since it is in an SQ context. Under these conditions, we did
not observe induced phosphorylation of this protein in A-T
fibroblasts. Furthermore, IR (3Gy) failed to induce OSR1 phos-
phorylation, implying a H2O2-specific phosphorylation of
OSR1. H2O2-induced phosphorylation of two known sub-
strates of ATM (Mre11 and Rad50) was also observed (Fig.
6A). Similarly, H2O2-induced phosphorylation of two other
candidate proteins, HDGF and ccdc82 (Fig. 6A). Semi-quan-
titative analysis revealed that HDGF was induced 5.3-fold
compared with twofold in A-T cells. These differences in
phosphorylation follow the pattern observed in the MaxQuant
analysis (Supplemental Table I). In the case of ccdc82, the
increases were 2.5-fold and 1.5-fold, respectively, again
reflecting what was observed in the MS analysis; however,
this particular candidate was only detected twice in NFF and
therefore did not meet our stringent Set 3 criteria. Reduced
phosphorylation of these proteins was observed in A-T fibro-
blasts. A number of available antibodies against other candi-
date proteins containing p(S/T)Q sites (ATE1, METTL16,
TCEAL3, ATXN3, SNX17, MON1) were tested by immunoblot-
ting and IF microscopy but failed to demonstrate changes in
phosphorylation status or subcellular localization of these
proteins (data not shown).
Phosphorylation of S100A11 protein was also confirmed to
be ATM dependent in this study. S100A11 is a cytoplasmic
protein, involved in Ca2 signaling (76). This protein was
previously shown to be translocated to the nucleus by PKC-
mediated phosphorylation in response to transforming growth
factor  treatment (77). We also observed diffuse cytoplasmic
staining for S100A11 in NFF cells that translocated to the
nucleus in response to H2O2 treatment (Fig. 7A). S100A11
was also localized to the cytoplasm in A-T fibroblasts, but the
distribution was more perinuclear compared with NFF fibro-
blasts and it failed to be translocated to the nucleus after
H2O2 treatment. Colocalization was not observed with an
early endosome marker, EEA1. Translocation of S100A11 un-
der conditions that detect formation of H2O2-induced H2AX
foci by immunofluorescence microscopy demonstrated that
nuclear staining of S100A11 did not coincide with DNA dam-
age foci (Fig. 7B).
DISCUSSION
ATM plays a central role in the response to DNA double
strand breaks, phosphorylating upwards of 700 substrates
that are involved in a variety of cellular processes that include
cell cycle control, DNA repair, transcription, apoptosis, and
cell proliferation (4). However, it is now evident that ATM is
also activated by other DNA-damaging agents, chromatin
FIG. 6. Detection of candidate proteins from phosphoproteomics
screen in phospho-(S/T)Q ATM/ATR substrate antibody immuno-
precipitates. Extracts from untreated, irradiated (3 Gy) and hydro-
gen-peroxide-treated normal human fibroblasts (NFF) and A-T fi-
broblasts were prepared as described in the Methods and
immunoprecipitated with p-(S/T)Q ATM/ATR substrate antibodies.
Immunoprecipitates and extracts were run on 4–12% NuPage gels
and gels were transferred to nitrocellulose membrane and stained
with Ponceau S to estimate the loading. Western blotting was
performed with antibodies against a selection of candidate pro-
teins from the phosphoproteomics screen. listtext(A) (B) HDGF and
ccdc82. * Western blotting with antibodies against known substrates of
ATM kinase (Mre11, Rad50) was performed to access the efficiency of
p(S/T)Q antibodies imunnoprecipitations.
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modification and by oxidative stress not involving damage to
DNA (9). In order to elucidate the pathways activated by the
different agents, it is important to identify the substrates that
mediate the various effects. In the present study, we em-
ployed oxidative stress (H2O2) to identify proteins phosphor-
ylated by ATM with a view to understanding the defective
phenotype in A-T.We selected a concentration of H2O2 that lead
to elevated ATM activation in both the nucleus and cytoplasm.
FIG. 7. Translocation of S100A11 to the nucleus in response to H2O2 treatment is defective in A-T fibroblasts. Normal control
fibroblasts (NFF) and A-T fibroblasts were grown on coverslips, treated with hydrogen peroxide, or left untreated as described in the Methods.
IF microscopy was performed using antibodies against EEA1 and S100A11 (A) or H2AX and S100A11 (B). Cells were imaged on a Zeiss
AxioImager M1 fluorescent microscope using x63 oil lens. Images were taken with an Axiocam503 mono camera and processed using ZEN
software (Zeiss). Separate channels and merged images are shown. The scale bar is 10 M.
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The presence of ATM in the cytoplasm is in keeping with
previous reports for a number of different cells including post-
mitotic cells (11, 28, 29, 38). While a number of cytoplasmic
proteins have been shown to be phosphorylated after ATM
activation by DNA-damaging agents (28, 42–50), the only
direct evidence for activation in the cytoplasm has only re-
cently been demonstrated (10). In that report, they show that
ATM is localized to the peroxisome in agreement with earlier
observations (11). They also show that ATM localized to the
peroxisome via the import receptor PEX5. On exposure to
ROS, ATM becomes activated to phosphorylate PEX5 at
Ser140, which leads to its ubiquitylation and subsequent bind-
ing to p62 to induce pexophagy. We did not detect PEX5
among the list of substrates phosphorylated by ATM, but we
did observe phosphorylation of other peroxisomal proteins:
PEX1 (SQ site), PEX10, PEX14, and PEX19.
Here, we have provided evidence that cytoplasmic ATM is
activated by autophosphorylation on Ser1981 and additional
sites (Ser367 and Ser2996). ATM was shown to be present in
the cytoplasm of different cell types, and cytoplasmic sub-
strates were identified after DNA damage. However, it was not
clear whether cytoplasmic ATM was functioning as a protein
kinase. Furthermore, we have identified a number of cytoplas-
mic substrates after activation of ATM by oxidative stress.
We applied a quantitative phosphoproteomics analysis us-
ing a modified TiSH global phosphoproteomics approach (56)
to identify proteins altered in their phosphorylation state in
normal fibroblasts and A-T cells in response to oxidative
damage. Contributions from other members of the PIKK fam-
ily are difficult to rule out. However, our parallel screening in
A-T cells allowed an additional level of classification of can-
didate ATM substrate phosphosites. For example, in Sets 1
and 3, we identified cytoplasmic proteins that are likely to be
bona fide ATM/ATR substrates, along with sites not confined
to the p(S/T)Q motif. This is all that not surprising since ATM
was previously shown to phosphorylate sites other than
(S/T)Q (23).
We identified a total of 9,833 phosphorylation sites, in-
cluding 6,686 high-confidence sites. For subsequent bioin-
formatics analyses, results were divided into four data sets:
those differentially phosphorylated in NFF and A-T fibro-
blasts (Set 1); those present preferentially in A-T cells (Set
2); those present preferentially in normal cells (Set 3); and
those phosphorylated in both (Set 4). This approach en-
abled us to identify a 101 robustly regulated phosphopep-
tides for further analyses. Sets 1 and 3 were identified as
preferentially enriched in ATM consensus (S/T)Q sites (51),
using an unbiased method.
Of these 11 (S/T)Q sites identified in Set 1 and 3, two of the
proteins, HMGA1 and UIMC1 (RAP80), had already been
shown to be substrates for ATM in response to DNA damage
(72, 73). The high mobility group protein, HMGA1, which plays
a role in chromosomal organization, transcription regulation,
and response to DNA damage, interacts with ATM and is a
target for this kinase. HMGA1 is phosphorylated on Ser88 after
DNA damage, but we observed ATM-dependent phosphory-
lation at a second site: Ser9. Both sites are highly conserved
in mammals. The ubiquitin interaction motif domain-contain-
ing protein, RAP80, has been shown to be a substrate for
ATM Ser205 (73). Again, in this case, we identified a different
site Ser101 of ATM-dependent phosphorylation. Of the re-
maining nine candidates identified, two, OSR1 and PPM1G,
were identified in a previous phosphoproteomics screens af-
ter DNA damage (21, 25). The splicing-regulator phosphatase
PPM1G was phosphorylated at Ser183 and Ser201, both of
which are PIKK sites. Where cells were treated with either
etoposide or IR, PPM1Gwas recruited to DNA-damaged sites a
short time after irradiation, but it was not reported whether
phosphorylation at either of these sites influenced recruitment.
PPM1G responded similarly to IR and etoposide in the Beli et al
study.
We demonstrated that the oxidative stress responsive 1
protein (OSR1) was sixfold up-regulated in response to H2O2
treatment at a non-(S/T)Q site and 1.5-fold up-regulated at an
(S/T)Q Ser427 site (n  2), which was supported by p(S/T)Q-
specific immunoblot analysis. Under these conditions, no in-
duction was observed after IR treatment and failure to obtain
an induction in A-T cells supports the ATM dependence of this
phosphorylation. Previous data have shown that OSR1 is
activated only by oxidative stress, notably sorbitol hypotonic-
ity, and, to a lesser extent, NaCl (78). This protein kinase in
turn has been shown to directly phosphorylate the N-terminal
regulatory regions of calcium-chloride-transporters, including
NKCCI, NKCC2, and NCC (79). However, since A-T is not
characterized by channelopathy, it is possible that the re-
sponse of OSR1 to oxidative stress is mediated through other
undefined substrates, which might impact on other aspects
of the A-T phenotype. An increased level of phosphor-
ylation in response to H2O2 was observed for both HDGF and
ccdc82 in control cells compared with A-T. HDGF, present in
both the cytoplasm and nucleus, plays an important role in
normal tissue development and is frequently overexpressed
in cancer (80). It is not clear how phosphorylation affects the
activity of this survival factor. Since ATM functions to protect
against cancer (reviewed in (32)), it is possible that phosphor-
ylation alters HDGF activity.
The cytoplasmic protein S100A11 showed a 3.3-fold (aver-
age) increase in phosphorylation in control versus A-T cells
treated with H2O2. However, immunoblotting following immu-
noprecipitation with anti-p(S/T)Q motif antibody did not con-
firm the increase in phosphorylation detected using quantita-
tive mass spectrometry. This is not too surprising since
immunoprecipitation with anti-(S/T)Q antibody does not de-
tect all known radiation-induced protein phosphorylations
(our unpublished data). However, treatment of control cells
with H2O2 caused S100A11 protein to relocalize from the
cytoplasm to the nucleus in up to 60% of cells. On the other
hand, the S100A11 was largely deficient in localizing to the
ROS and ATM-Dependent Cytoplasmic Phosphoproteome
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nucleus in A-T cells in response to H2O2. Overall, this sug-
gests that S100A11 phosphorylation results in it being local-
ized to the nucleus, and this is markedly reduced in A-T cells
due to reduced phosphorylation in the absence of ATM.
S100A11 is a member of the S100 family of Ca2-binding
proteins that are involved in cell cycle progression and signal
transduction (81). Murzik et al. (82) have shown that Rad54B
targeting to DNA double strand breaks requires complex for-
mation with S100A11 implicating this protein in DNA repair.
Furthermore, DNA damage involves a nucleolin-mediated
translocation of S100A11 from the cytoplasm to the nucleus
that is dependent on the phosphorylation activity of PKC
(83). It appears likely that this translocation of S100A11 into
the nucleus may inhibit cell proliferation through increased
levels of the cyclin kinase inhibitor p21 (84). S100A11 contains
a single SQ site (Ser101) close to the C terminus of the protein,
which we demonstrated was phosphorylated to a greater extent
in normal fibroblasts after H2O2 treatment. This suggests that
ATM-dependent phosphorylation of S100A11 also controls its
entry into the nucleus and perhaps involvement in DNA repair
and response to oxidative stress. Further analysis was also
carried out with other candidate substrates identified (ATE1,
METTL16, TCEAL3, ATXN3, SNX17, and MON1) for which an-
tibodies were available, but none showed evidence of increased
phosphorylation or cellular redistribution (data not shown).
In summary, we have identified 2,716 proteins which dem-
onstrated phosphorylation changes in response to oxidative
damage in the cytoplasm. Of these, 43 were phosphory-
lated in normal fibroblasts but not in A-T cells, and a further 19
were differentially phosphorylated. These sets were enriched
for the known (S/T)Q motif and predicted ATM targets. We
validated phosphorylation changes for some of these proteins
based on known function and relationship to the A-T pheno-
type. The challenge ahead is to confirm additional sites of
phosphorylation and to investigate the effect of phosphor-
ylation on function and how it impacts on the A-T phenotype.
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